Loading…

KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis

KDM4/JMJD2 Jumonji C-containing histone lysine demethylases (KDM4A–D) constitute an important class of epigenetic modulators in the transcriptional activation of cellular processes and genome stability. Interleukin-8 (IL-8) is overexpressed in gastric cancer, but the mechanisms and particularly the...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease 2019-01, Vol.10 (2), p.68, Article 68
Main Authors: Wu, Meng-Chen, Cheng, Hsin-Hung, Yeh, Ta-Sen, Li, Yi-Chen, Chen, Tsan-Jan, Sit, Wei Yang, Chuu, Chih-Pin, Kung, Hsing-Jien, Chien, Shu, Wang, Wen-Ching
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:KDM4/JMJD2 Jumonji C-containing histone lysine demethylases (KDM4A–D) constitute an important class of epigenetic modulators in the transcriptional activation of cellular processes and genome stability. Interleukin-8 (IL-8) is overexpressed in gastric cancer, but the mechanisms and particularly the role of the epigenetic regulation of IL-8, are unclear. Here, we report that KDM4B, but not KDM4A/4C, upregulated IL-8 production in the absence or presence of Helicobacter pylori . Moreover, KDM4B physically interacts with c-Jun on IL-8 , MMP1 , and ITGAV promoters via its demethylation activity. The depletion of KDM4B leads to the decreased expression of integrin αV, which is exploited by H. pylori carrying the type IV secretion system, reducing IL-8 production and cell migration. Elevated KDM4B expression is significantly associated with the abundance of p-c-Jun in gastric cancer and is linked to a poor clinical outcome. Together, our results suggest that KDM4B is a key regulator of JNK/c-Jun-induced processes and is a valuable therapeutic target.
ISSN:2041-4889
2041-4889
DOI:10.1038/s41419-019-1305-y